PuSH - Publication Server of Helmholtz Zentrum München

42 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Blank, S. et al.: Prevalence of Hymenoptera venom allergy and sensitization in the population-representative German KORA cohort. Allergo J. Int., accepted (2019)
Gutermuth, J.* ; Schmidt-Weber, C.B. & Blank, S.: Supporting allergen-specific immunotherapy by inhibition of Janus kinases. Allergy, accepted (2019)
Mehlich, J.* et al.: The basophil activation test differentiates between patients with alpha-gal syndrome and asymptomatic alpha-gal sensitization. J. Allergy Clin. Immunol. 143, 182-189 (2019)
Pali-Schöll, I.* et al.: EAACI position paper: Comparing insect hypersensitivity induced by bite, sting, inhalation or ingestion in human beings and animals. Allergy, accepted (2019)
Russkamp, D. et al.: IL-4 receptor α blockade prevents sensitization and alters acute and long-lasting effects of allergen-specific immunotherapy of murine allergic asthma. Allergy, accepted (2019)
Blank, S. ; Bilò, M.B.* & Ollert, M.*: Component-resolved diagnostics to direct in venom immunotherapy: Important steps towards precision medicine. Clin. Exp. Allergy 48, 354-364 (2018)
Dittmar, M. et al.: Immunological characterization of Polistes dominula venom and identification of the hyaluronidase Pol d 2. Allergy 73, 42-42 (2018)
Eberlein, B.* et al.: Differences of Pol d 3 and Ves v 3 induced basophil activation between Spanish and German insect venom allergic patients. Allergy 73, 634-635 (2018)
Heldner, A. et al.: Influence of synbiotics on the t cell response of grass pollen-allergic individuals in vitro. Allergy 73, 584-584 (2018)
Russkamp, D. et al.: Characterization of the honeybee venom proteins C1q-like protein and PVF1 and their allergenic potential. Toxicon 150, 198-206 (2018)
Schiener, M. et al.: The high molecular weight dipeptidyl peptidase IV Pol d 3 is a major allergen of Polistes dominula venom. Sci. Rep. 8:1318 (2018)
Aguilar-Pimentel, J.A. et al.: Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthma. PLoS ONE 12:e0178563 (2017)
Blank, S. et al.: Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergy. Hum. Vaccin. Immunother. 13, 2482-2489 (2017)
Graessel, A. et al.: Interference into JAK/stat signalling-a concept for improved allergen-specific immunotherapy? Allergy 72, 40-40 (2017)
Russkamp, D. et al.: Component-resolved allergen content of therapeutic honeybee venom extracts. Allergy 72, 18-18 (2017)
Schiener, M. ; Graessel, A. ; Ollert, M.* ; Schmidt-Weber, C.B. & Blank, S.: Allergen-specific immunotherapy of Hymenoptera venom allergy - also a matter of diagnosis. Hum. Vaccin. Immunother. 13, 2467-2481 (2017)
Schiener, M. et al.: Polistes venom allergy: Identification and immunological characterization of novel allergens. Allergy 72, 17-18 (2017)
Aguilar-Pimentel, J.A. et al.: Experimental allergen-specific immunotherapy under the umbrella of JAK1/3 pathway inhibition substantial improved local parameters of allergic airway inflammation. Allergy 71, 507-507 (2016)
Blank, S. ; Schiener, M. & Ollert, M.*: Allergies due to stings and bites of insects and arachnids. Allergologie 39, 265-273 (2016)